E-LIB Suche - Ergebnisse für: Landgraf, Wolfgang

1

Responses to Basal Insulin Glargine (300 U/mL and 100 U/mL)..:

Landgraf, Wolfgang ; Owens, David R. ; Frier, Brian M..
Diabetes Therapy. 15 (2024) 8 - p. 1769-1784 , 2024

Link: https://doi.org/10.1007/..

2

Response to insulin glargine 100 U/mL treatment in newly-de..:

Landgraf, Wolfgang ; Bigot, Gregory ; Frier, Brian M...
Primary Care Diabetes. 17 (2023) 4 - p. 379-385 , 2023

Link: https://doi.org/10.1016/..

3

Comparative efficacy and safety of Gla‐300 versus IDegAsp i..:

Ritzel, Robert ; Ghosh, Sujoy ; Emral, Rifat...
Diabetes, Obesity and Metabolism. 25 (2023) 9 - p. 2495-2504 , 2023

Link: https://doi.org/10.1111/..

4

Treatment responses to basal insulin glargine 300 U/ml and ..:

Landgraf, Wolfgang ; Owens, David R. ; Frier, Brian M..
Diabetes, Obesity and Metabolism. 26 (2023) 2 - p. 503-511 , 2023

Link: https://doi.org/10.1111/..

5

Distribution and characteristics of newly-defined subgroups..:

Landgraf, Wolfgang ; Bigot, Gregory ; Hess, Sibylle...
Diabetes Research and Clinical Practice. 190 (2022) - p. 110012 , 2022

Link: https://doi.org/10.1016/..

6

Hypoglycaemia risk with insulin glargine 300 U/mL compared ..:

Bolli, Geremia B. ; Landgraf, Wolfgang ; Bosnyak, Zsolt..
Diabetes, Obesity and Metabolism. 22 (2020) 9 - p. 1664-1669 , 2020

Link: https://doi.org/10.1111/..

7

Fasting C‐peptide, a biomarker for hypoglycaemia risk in in..:

Landgraf, Wolfgang ; Owens, David R. ; Frier, Brian M...
Diabetes, Obesity and Metabolism. 22 (2019) 3 - p. 315-323 , 2019

Link: https://doi.org/10.1111/..

8

Commencing insulin glargine 100 U/mL therapy in individuals..:

Owens, David R. ; Landgraf, Wolfgang ; Frier, Brian M....
Diabetes, Obesity and Metabolism. 21 (2019) 2 - p. 321-329 , 2019

Link: https://doi.org/10.1111/..

9

Glycaemic responses in Asian and non-Asian people with type..:

Chan, Juliana C.N. ; Bunnag, Pongamorn ; Chan, Siew P....
Diabetes Research and Clinical Practice. 135 (2018) - p. 199-205 , 2018

Link: https://doi.org/10.1016/..

10

Hypoglycaemia risk in the first 8 weeks of titration with i..:

Frier, Brian M. ; Landgraf, Wolfgang ; Zhang, Mei..
Diabetes, Obesity and Metabolism. 20 (2018) 12 - p. 2894-2898 , 2018

Link: https://doi.org/10.1111/..

11

The use of lipid-lowering therapy and effects of antihyperg..:

Hanefeld, Markolf ; Traylor, Louise ; Gao, Ling.
Cardiovascular Diabetology. 16 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

12

Effects of age, gender, and body mass index on efficacy and..:

Owens, David R. ; Bolli, Geremia B. ; Charbonnel, Bernard...
Diabetes, Obesity and Metabolism. 19 (2017) 11 - p. 1546-1554 , 2017

Link: https://doi.org/10.1111/..

13

Patient-level meta-analysis of efficacy and hypoglycaemia i..:

Owens, David R. ; Traylor, Louise ; Mullins, Peter.
Diabetes Research and Clinical Practice. 124 (2017) - p. 57-65 , 2017

Link: https://doi.org/10.1016/..

14

Plasma C-Peptide Concentration and Risk of Hypoglycemia in ..:

Bolli, Geremia ; Ritzel, Robert ; Yale, Jean-François...
Canadian Journal of Diabetes. 41 (2017) 5 - p. S57 , 2017

Link: https://doi.org/10.1016/..

15

Comparison of glycemic control in Asian and non-Asian T2D p..:

Tsai, Shih-Tzer ; Chan, Juliana ; Bunnag, Pongamorn...
Diabetes Research and Clinical Practice. 120 (2016) - p. S114-S115 , 2016

Link: https://doi.org/10.1016/..